Safar P
Circulation. 1986 Dec;74(6 Pt 2):IV138-53.
Cerebral neurons can tolerate at least 20 min of normothermic ischemic anoxia. Cerebral recovery from more than 5 min of cardiac arrest is hampered by complex secondary derangements of multiple organ systems after reperfusion. There is increasing support of our hypothesis that this "postresuscitation syndrome" includes the following: secondary cerebral perfusion failure, cerebral reoxygenation injury (cell-necrotizing cascades), and cerebral "intoxication" from derangements of extracerebral organs. To be optimal for the brain, CPR with optimal perfusion pressure must be started as promptly as possible. Significant though inconsistent mitigation of permanent brain damage after prolonged complete global brain ischemia has been achieved in animal outcome preparations with the use of the following treatments initiated at the start of reperfusion: brain-oriented extracerebral life support by protocol, intra-arterial hemodilution, hypertension, and artificial circulation, barbiturates, calcium-entry blockers, free-radical scavengers, and multifaceted treatments. We currently recommend treatment 1 for patient care and treatment 2 for clinical feasibility trials. Treatment 3, thiopental loading (starting 10 to 50 min after restoration of spontaneous circulation), was tested in a randomized clinical trial and was not shown to confer a statistically significant benefit. A calcium-entry blocker is under clinical investigation. Many other novel treatments appear promising but further animal studies are required. The complex multifactorial pathogenesis of postcardiac arrest encephalopathy requires systematic multicenter development of etiology-specific combination therapies.
脑神经元能够耐受至少20分钟的正常体温下的缺血性缺氧。心脏骤停超过5分钟后,脑复苏会受到再灌注后多器官系统复杂的继发性紊乱的阻碍。我们的假设越来越得到支持,即这种“复苏后综合征”包括以下方面:继发性脑灌注衰竭、脑再氧合损伤(细胞坏死级联反应)以及脑外器官紊乱导致的脑“中毒”。为了对大脑最为有利,必须尽快开始具有最佳灌注压力的心肺复苏。在动物实验中,通过在再灌注开始时采用以下治疗方法,已经在延长的完全性全脑缺血后显著减轻了永久性脑损伤,尽管效果并不一致:按照方案进行的以脑为导向的脑外生命支持、动脉内血液稀释、高血压和人工循环、巴比妥类药物、钙通道阻滞剂、自由基清除剂以及多方面治疗。我们目前推荐治疗1用于患者护理,治疗2用于临床可行性试验。治疗3,硫喷妥钠负荷剂量(在自主循环恢复后10至50分钟开始),在一项随机临床试验中进行了测试,未显示出具有统计学意义的益处。一种钙通道阻滞剂正在进行临床研究。许多其他新的治疗方法看起来很有前景,但还需要进一步的动物研究。心脏骤停后脑病的复杂多因素发病机制需要针对病因的联合疗法进行系统的多中心开发。